Table of Contents
CHAPTER ONE: EXECUTIVE SUMMARY
- Market Drivers
- Market Size and Growth
- Total Implantable/Injectable Drug Delivery Marke
- The Implantable/Injectable Drug Delivery Only Market
- Competitor and Market Analysis
CHAPTER TWO: INTRODUCTION
- Scope and Methodology
- Reasons for Injectable/Implantable Drug Delivery Systems
- History of Injectable/Implantable Drug Delivery
- Phases of Drug Action
- Needle-Free Drug Delivery
- Auto-injectors
- Pen Injectors
- Major Applications
- Safety Concerns
- Products
- Implantable Drug Delivery
- Mechanisms
- Applications
- Products
- Sustained-Release Drug Delivery
- Products
- Targeted Injection Drug Delivery
- Products
- Lipsome
- Niosome
- Microspheres and Nanoparticles
- Cyclodetrins
- Prodrug
- Polymeric Micelles
- PEGylation
CHAPTER THREE: TRENDS AND DEVELOPMENTS
- Drivers of the Implantable/Injectable Drug Delivery Market
- Pen Injectors
- Proprietary Product Development
- Delivery Systems Placement Trends
- Therapeutic Trends
- Incorporation of Technology
- Nanotechnology
- Drug Delivery Development
- Microsphere Technology
- Targeted Technology
- MicroChip Technology
- Protein-Coated Microcrystal Technology
- Needle-Free Delivery Development
- Selected Products in Development
CHAPTER FOUR: MARKET SIZE AND GROWTH
- The Total Implantable/Injectable Drug Delivery Market
- Injectable/Implantable Delivery Technology Only Market
CHAPTER FIVE: COMPETITIVE AND MARKET ANALYSIS
- Competitive Landscape
- Market Analysis
CHAPTER SIX: COMPANY PROFILES
- Alkermes, Inc.
- ALZA Corp.
- Antares Pharma, Inc.
- Bioject Medical Technologies, Inc.
- CyDex, Inc.
- MGI Pharma, Inc
- Nektar Therapeutics
- Pacira Pharmaceuticals, Inc.
- pSivida
- SurModics, Inc
- Zogenix Corporation
- COMPANIES IN BRIEF
- AP Pharma
- Baxter BioPharma Solutions
- QLT USA, Inc
- Ypsomed Holding AG
- APPENDIX: COMPANY DIRECTORY
TABLE OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
Figure 1-1 The Worldwide Market for Implantable/Injectable Drug Delivery
Technology and Pharmaceuticals 2003-201
CHAPTER TWO: INTRODUCTION
- Table 2-1 Sequence of Drug Action
- Table 2-2 Marketed Products Using Liposomal Drug Delivery
- Table 2-3 Marketed Products Using Nanoparticle Drug Delivery
CHAPTER THREE: TRENDS AND DEVELOPMENTS
- Table 3-1 Select Products in Development by Drug Delivery Companies
CHAPTER FOUR: MARKET SIZE AND GROWTH
- Table 4-1 The Worldwide Market for Implantable/Injectable Drug Delivery
Technology and Pharmaceuticals 2003-2013
- Figure 4-1 The Worldwide Market for Implantable/Injectable Drug Delivery
Technology and Pharmaceuticals 2003-2013
- Table 4-2 The Worldwide Market for Pharmaceuticals Utilizing
Injectable/Implantable Drug Delivery by Type 2003-2013
- Figure 4-2 The Worldwide Market for Pharmaceuticals Utilizing
Injectable/Implantable Drug Delivery by Type 2003-2013
- Table 4-3 The Worldwide Market for Pharmaceuticals Utilizing
Injectable/Implantable Drug Delivery Market Share by Type 2003-2013
- Figure 4-3 The Worldwide Market for Pharmaceuticals Utilizing
Injectable/Implantable Drug Delivery Market Share by Type 2008
- Figure 4-4 The Worldwide Market for Pharmaceuticals Utilizing
Injectable/Implantable Drug Delivery Market Share by Type 2013
- Table 4-4 The Worldwide Market for Injectable/Implantable Drug Delivery
Systems by Pharmaceutical and Drug Delivery Component 2003-2013
- Table 4-5 The Worldwide Market for Injectable/Implantable Drug Delivery
Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component
2003-2013
- Figure 4-5 The Worldwide Market for Injectable/Implantable Drug Delivery
Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component
2008
- Figure 4-6 The Worldwide Market for Injectable/Implantable Drug Delivery
Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component
2013
CHAPTER FIVE: COMPETITIVE AND MARKET ANALYSIS
- Table 5-1 Leading Suppliers of Implantable/Injectable Drug Delivery
Technology
- Figure 5-1 Cost per Million Injections by Injector Type
|
Related Report
|
View Cart
